Kalcicur (Calcium)

Calcium ions are essential for many physiological processes. When administered intravenously, calcium raises extracellular calcium levels, which stabilizes neuronal and cardiac cell membranes, reduces excitability, and counteracts the effects of excess potassium. It also provides the mineral needed for bone mineralization and acts as a co‑factor for numerous enzymatic reactions.

The dose of Kalcicur is determined by the prescribing clinician based on the patient’s serum calcium level, clinical condition, and weight. Healthcare professionals calculate the appropriate volume and rate of infusion to achieve the desired correction while minimizing the risk of rapid calcium shifts.

Safety data for intravenous calcium in pregnancy and lactation are limited. Use of Kalcicur during pregnancy or while breastfeeding should only be considered when the potential benefits outweigh any possible risks, and it must be prescribed and monitored by a qualified healthcare provider.

To order Kalcicur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and any required import documentation.

Kalcicur is supplied as a sterile intravenous solution, offering rapid correction of calcium deficits compared with oral calcium salts, which require gastrointestinal absorption. Compared with other IV calcium products such as calcium gluconate or calcium chloride, Kalcicur’s formulation and concentration are selected for specific clinical protocols, but the choice depends on the therapeutic goal, required calcium load, and patient tolerance.

Kalcicur must be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Before use, inspect the vial for particulate matter or discoloration. Maintain aseptic technique during preparation and administration, and keep the product within the recommended temperature range until the point of infusion.

Kalcicur is administered intravenously by a qualified healthcare professional. The solution is typically diluted in an appropriate compatible fluid and infused slowly, often over 10‑20 minutes, while monitoring the patient’s vital signs and cardiac rhythm. Administration guidelines are provided by the prescriber and the product’s labeling.

Serious risks include cardiac arrhythmias, especially if infused too rapidly, severe hypercalcemia leading to neurological or renal complications, tissue necrosis from extravasation, and rare anaphylactic reactions. Continuous cardiac monitoring and careful infusion techniques are essential to mitigate these risks.

Kalcicur should be avoided in patients with known hypersensitivity to calcium preparations, severe hypercalcemia, or those with conditions that predispose to calcium precipitation such as severe renal failure without appropriate monitoring. It should also be used with caution in patients receiving digoxin, digitalis, or certain diuretics, and only under medical supervision.